There could be new hope for ALS management as a promising drug enters phase 3 clinical trials. ALS is a progressive disease in which the brain loses connection with the muscles, The ALS Association ...
Amyotrophic lateral sclerosis remains difficult to diagnose and is frequently identified after substantial disease progression, underscoring the need for earlier recognition and expanded therapeutic ...
When the results of the first-ever platform trial for amyotrophic lateral sclerosis (ALS) were published this February, the headlines might have seemed disappointing: four experimental drugs failed to ...
In a June 2025 interview, Dane shared that his ALS symptoms had started about a year and a half prior — late 2023 or early ...
New hope could be on the horizon for ALS patients in the form of a "breakthrough" drug, researchers say. Neuvivo, a California biopharmaceutical company that develops therapies for neurodegenerative ...
Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease, is a neurodegenerative disease that affects the neurons in the brain and spinal cord. In the United States alone there are ...
Eric Dane offered insight into the progression of his ALS diagnosis before his death at age 53. Dane revealed his health battle in April 2025. ALS stands for amyotrophic lateral sclerosis, a nervous ...
New ALS drug enters human trials after reversing a key protein in animals and could change the future of treatment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results